Annual Hematology Retreat 2023
The 2nd Annual Hematology Division Research Retreat was held on November 17th, with insightful presentations and engaging discussions amongst Hematology trainees and faculty. Faculty presentations were given by Luis Batista, Ben Jennings, Andrew Young, and Amber Afzal. Trainee oral presentations were delivered by Fan He (Oh Lab), Jeeseung Kim (Kang Lab), and Jingu Lee (Cho Lab). The J. Evan […]
49th Annual Carl Vernon Moore Memorial Lecture
The 49th annual Carl Moore Memorial Lecture was held on November 8, 2023 with invited speaker Katherine High, M.D., discussing her pioneering work developing gene therapy approaches for genetic diseases. The lectureship is in honor of Dr. Carl Moore, a renowned physician-scientist who established the Division of Hematology and later served as Chair of the […]
2023 Castle Connolly Top Doctors (Links to an external site)
The Department of Medicine is proud to announce that 112 of our faculty have been selected for the 2023 Castle Connolly Top Doctors® list.
Siteman Investment Program awards $2 million in cancer research grants (Links to an external site)
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is pleased to announce funding for eight new projects, including research projects focused on prostate cancer, lymphoma, and breast cancer, as well as a team science project with a focus on myeloproliferative neoplasms, a blood malignancy that can develop into acute myeloid leukemia. Also included are two […]
WashU HemeOnc Fellowship Program (Links to an external site)
Information about the Washington University in St. Louis Hematology-Oncology Fellowship Training Program.
2019-2022 DOM Awards Recognition Reception (Links to an external site)
Congratulations to all the Department of Medicine Awardees!
Possible treatment strategy identified for bone marrow failure syndrome (Links to an external site)
Bone marrow is the spongy tissue inside bone responsible for making red blood cells, white blood cells and platelets. Bone marrow failure syndromes lead to an increased risk of developing dangerous infections, anemia and an increased risk of blood cancers.
Study reveals how chronic blood cancer transitions to aggressive disease (Links to an external site)
A type of chronic leukemia can simmer for many years. Some patients may need treatment to manage this type of blood cancer — called myeloproliferative neoplasms (MPN) — while others may go through long periods of watchful waiting. But for a small percentage of patients, the slower paced disease can transform into an aggressive cancer, […]